HealthEquity, Inc. (HQY): Price and Financial Metrics
HealthEquity, Inc. (HQY)
Today's Latest Price: $84.31 USD
Updated Jan 21 1:08pm
Add HQY to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 8 in Medical - Health Insurance
See all "A" rated Strong Buy stocks
HQY Stock Summary
- HQY's current price/earnings ratio is 1,917.13, which is higher than 99.38% of US stocks with positive earnings.
- Price to trailing twelve month operating cash flow for HQY is currently 41.43, higher than 88.36% of US stocks with positive operating cash flow.
- Revenue growth over the past 12 months for Healthequity Inc comes in at 83.63%, a number that bests 93.61% of the US stocks we're tracking.
- If you're looking for stocks that are quantitatively similar to Healthequity Inc, a group of peers worth examining would be CYBR, SGH, ONTO, NOK, and KAMN.
- Visit HQY's SEC page to see the company's official filings. To visit the company's web site, go to www.healthequity.com.
HQY Stock Price Chart Interactive Chart >
HQY Price/Volume Stats
| Current price | $84.31 | 52-week high | $88.78 |
| Prev. close | $81.60 | 52-week low | $34.40 |
| Day low | $81.50 | Volume | 292,039 |
| Day high | $84.43 | Avg. volume | 725,309 |
| 50-day MA | $70.50 | Dividend yield | N/A |
| 200-day MA | $59.01 | Market Cap | 6.49B |
HealthEquity, Inc. (HQY) Company Bio
HealthEquity Inc. provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company was founded in 2002 and is based in Draper, Utah.
HQY Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $84.31 | $78.54 | -4% |
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Healthequity Inc. To summarize, we found that Healthequity Inc ranked in the 51th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. The most interesting components of our discounted cash flow analysis for Healthequity Inc ended up being:
- The company's compound free cash flow growth rate over the past 5.5 years comes in at 0.59%; that's greater than 83.21% of US stocks we're applying DCF forecasting to.
- Healthequity Inc's weighted average cost of capital (WACC) is 10%; for context, that number is higher than 65.53% of tickers in our DCF set.
- Relative to other stocks in its sector (Technology), Healthequity Inc has a reliance on debt greater than 66.33% of them.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -6% |
| 1% | -5% |
| 2% | -4% |
| 3% | -3% |
| 4% | -2% |
| 5% | -1% |
For other companies in the Technology that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as HQY, try AMZN, CIEN, GDDY, CLRO, and IIVI.
Loading social stream, please wait...